Skip to main content
. 2022 Jul 8;24(3):305. doi: 10.3892/ol.2022.13425

Table I.

Patient's characteristics.

Clinical factors Group N (%)
Age ≤60 years 26 (17.1)
>60 and ≤70 years 79 (52.0)
>70 years 47 (30.9)
Gleason score ≤6 78 (51.3)
7 49 (32.2)
>7 25 (16.4)
PSA <10 ng/ml 67 (44.1)
10-20 ng/ml 36 (23.7)
>20 ng/ml 48 (31.6)
Missing 1 (0.7)
Smoking No 76
Yes 76
ZUBROD 0 116 (76.3)
1 35 (23.0)
2 1 (0.7)
Co morbid conditions Yes 92 (60.5)
Diabetes 8 (5.3)
Hypertension 68 (44.7)
Cardiological diseases 36 (23.7)
Cancer in family history 68 (44.7)
Treatment Surgery 21 (13.8)
Radical radiotherapy 124 (81.6)
Cyberknife treatment 13 (8.6)
Hormonotherapy 125 (82.2)

PSA, prostate-specific antigen; ZUBROD, performance scale.